SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 13, 2017
Medidata Solutions, Inc.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
350 Hudson Street
New York, New York
(Address of principal executive offices)
Registrant’s telephone number, including area code: (212) 918-1800
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d 2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective December 13, 2017, Michael Capone, who has been Chief Operating Officer of Medidata Solutions, Inc. (the “Company”), is no longer employed by the Company. Mr. Capone’s areas of responsibility will be managed by the Company’s CEO and President.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDIDATA SOLUTIONS, INC.
Date: December 13, 2017
By: /S/ MICHAEL I. OTNER
Name: Michael I. Otner
Executive Vice President—General Counsel